Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation

Endocrine Practice

Volumn 11, Issue 3, 2005, Pages 184-189

  Flores, Jose C ^a   Burton, Doug W ^b   Arnell, Paula M ^a   Deftos, Leonard J ^b   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CALCIUM CARBONATE; CYCLOPHOSPHAMIDE; DOPAMINE RECEPTOR STIMULATING AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN ANTIBODY; TUMS; VINCRISTINE; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE;

AGED; ARTICLE; BONE MARROW BIOPSY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CASE REPORT; DISEASE COURSE; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HYPERCALCEMIA; MALE; PROLACTINOMA; RHABDOMYOSARCOMA; SPHENOID SINUS; STAINING; BIOSYNTHESIS; BONE MARROW CANCER; BRAIN TUMOR; ENZYME IMMUNOASSAY; FATALITY; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; PATHOLOGY;

AGED; BONE MARROW NEOPLASMS; BRAIN NEOPLASMS; DIPHOSPHONATES; FATAL OUTCOME; HUMANS; HYPERCALCEMIA; IMIDAZOLES; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID HORMONE-RELATED PROTEIN; PITUITARY NEOPLASMS; RHABDOMYOSARCOMA; SPHENOID SINUS;

EID: 27744434505     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/ep.11.3.184     Document Type: Article

References (38)

1. Klibanski A, Zervas NT. Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med. 1991;324:822-831.
2. Plowman PN. Pituitary adenoma radiotherapy - when, who and how? Clin Endocrinol (Oxf). 1999;51:265-271.
3. Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med. 1997;103:134-145.
4. Burton DW, Brandt DW, Deftos LJ. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology. 1994;135:253-261.
5. Abdeen O, Pandol SJ, Burton DW, Deftos LJ. Parathyroid hormone-related protein expression in human gastric adenocarcinomas not associated with hypercalcemia. Am J Gastroenterol. 1995;90:1864-1867.
6. Bouvet M, Nardin SR, Burton DW, et al. Human pancreatic adenocarcinomas express parathyroid hormone-related protein. J Clin Endocrinol Metab. 2001;86:310-316.
7. Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol (Oxf). 1991;35:379-397.
8. Brada M, Ford D, Ashley S, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992;304:1343-1346.
9. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma: a report of four patients and estimation of risk [erratum in Cancer. 1994;73:492]. Cancer. 1993;72:2227-2233.
10. Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990. Clin Oncol (R Coll Radiol). 1994;6:361-363.
11. Foley JF, Lemon HM. Down's syndrome associated with an intracranial rhabdomyosarcoma and relative hypopituitarism. Nebr State Med J. 1968;53:384-388.
12. Jalalah S, Kovacs K, Horvath E, Couldwell W, Weiss MH, Ezrin C. Rhabdomyosarcoma in the region of the sella turcica. Acta Neurochir (Wien). 1987;88(3-4):142-146.
13. Arita K, Sugiyama K, Tominaga A, Yamasaki F. Intrasellar rhabdomyosarcoma: case report. Neurosurgery. 2001;48:677-680.
14. Ahmad K, Fayos JV. Pituitary fibrosarcoma secondary to radiation therapy. Cancer. 1978;42:107-110.
15. Amine AR, Sugar O. Suprasellar osteogenic sarcoma following radiation for pituitary adenoma: case report. J Neurosurg. 1976;44:88-91.
16. Tanaka S, Nishio S, Morioka T, Fukui M, Kitamura K, Hikita K. Radiation-induced osteosarcoma of the sphenoid bone. Neurosurgery. 1989;25:640-643.
17. Bloechle C, Peiper M, Schwarz R, Schroeder S, Zornig C. Post-irradiation soft tissue sarcoma. Eur J Cancer. 1995;31A:31-34.
18. Imhof SM, Moll AC, Hofman P, Mourits MP, Schipper J, Tan KE. Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with mega-voltage external beam irradiation. Doc Ophthalmol. 1997;93:337-344.
19. Miracco C, Materno M, De Santi MM, Pirtoli L, Ninfo V. Unusual second malignancies following radiation therapy: subcutaneous pleomorphic rhabdomyosarcoma and cutaneous melanoma; two case reports. J Cutan Pathol. 2000;27:419-422.
20. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341: 342-352.
21. Hawkins WG, Hoos A, Antonescu CR, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001;91:794-803.
22. Esnaola NF, Rubin BP, Baldini EH, et al. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001;234:215-223.
23. Little DJ, Ballo MT, Zagars GK, et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002;95:377-388.
24. Hutchinson RJ, Shapiro SA, Raney RB Jr. Elevated parathyroid hormone levels in association with rhabdomyosarcoma. J Pediatr. 1978;92:780-781.
25. Elomaa I, Lehto VP, Selander RK. Hypercalcemia and elevated serum parathyroid hormone level in association with rhabdomyosarcoma. Arch Pathol Lab Med. 1984; 108:701-703.
26. Leblanc A, Caillaud JM, Hartmann O, et al. Hyperealcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor: a study of 11 cases. Cancer. 1984;54: 2132-2136.
27. Nussbaum SR. Pathophysiology and management of severe hypercalcemia. Endocrinol Metab Clin North Am. 1993;22:343-362.
28. Almanaseer IY, Trujillo YP, Taxy JB, Okuno T. Systemic rhabdomyosarcoma with diffuse bone marrow involvement: case report of an unusual presentation. Am J Clin Pathol. 1984;82:349-353.
29. de la Serna JF, Martinez MA, Valdes MD, Hornedo J, Mestre MJ, Morales JM. Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failure. Med Pediatr Oncol. 1988;16:123-127.
30. Fortea Gimeno E, Indiano Arce JM, Rica Echevarria I, Mourelo Carballo C, Ereno Zarate C, Delgado Rubio A. Disseminated rhabdomyosarcoma of the bone, lung and bone marrow with severe hypercalcemia [article in Spanish]. An Esp Pediatr. 1990;33:576-578.
31. Kawasaki H, Takayama J, Nagasaki K, Yamaguchi K, Ohira M. Hypercalcemia in children with rhabdomyosarcoma. J Pediatr Hematol Oncol. 1998;20:327-329.
32. Choi YS, Lundy RO. Rhabdomyosarcoma and hypercalcemia. Arch Intern Med. 1989;149:1189.
33. Kattan J, Culine S, Terrier-Lacombe MJ, Theodore C, Droz JP. Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy. Ann Oncol. 1993;4:871-875.
34. Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med. 2000;342:177-185.
35. Guise TA, Mundy GR. Cancer and bone. Endocr Rev. 1998;19:18-54.
36. Guise TA, Yin JJ, Taylor SD, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest. 1996;98:1544-1549.
37. Nakamura M, Hashimoto T, Furuyama J, Kakudo K. Multiple alternative splice isoforms of parathyroid hormone-related peptide mRNA in human cell lines. J Mol Endocrinol. 1995;15:245-249.
38. Deftos LJ. Immunoassays for PTH and PTHrP: clinical applications. In: Bilezikian JP, Marcus R, Levine A, eds. The Parathyroids: Basic and Clinical Concepts. 2nd ed. San Diego, CA: Academic Press, 2001: 143-165.